GREGORY L WEAVER Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GREGORY L WEAVER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY L WEAVER. GREGORY L WEAVER is a Chief Financial Officer in Marina Biotech, Inc. ($MRNA) and a Director in Celsion CORP ($CLSN) and a in Eloxx Pharmaceuticals, Inc. ($ELOX) and a Chief Financial Officer in Eloxx Pharmaceuticals, Inc. ($SVON) and a Director in ATOSSA GENETICS INC ($ATOS) and a Director in Egalet Corp ($EGLT).
Address: 3450 MONTE VILLA PARKWAY BOTHELL 98021 WA
Companies in which GREGORY L WEAVER is an Insider
Adhera Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY L WEAVER: Chief Financial Officer
Holdings: 16,000 shares
Current Value: $3,200
Latest Transaction: May 27 2005
$ATRX Market Capitalization: $626850.00
$ATRX Previous Close: $0.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ATOSSA THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY L WEAVER: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 18 2021
$ATOS Market Capitalization: $6.08M
$ATOS Previous Close: $1.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Celsion CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY L WEAVER: Director
Holdings: 10,000 shares
Current Value: $3,500
Latest Transaction: Mar 26 2007
$CLSN Market Capitalization: $9.62M
$CLSN Previous Close: $0.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Eloxx Pharmaceuticals, Inc.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of GREGORY L WEAVER:
Holdings: 11,517 shares
Current Value: $2,649
Latest Transaction: Mar 16 2020
$ELOX Market Capitalization: $4.75M
$ELOX Previous Close: $0.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Zyla Life Sciences
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY L WEAVER: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 04 2019
$EGLT Market Capitalization: $112.49M
$EGLT Previous Close: $4.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GREGORY L WEAVER
Sentiment: All, ATRX, ATOS, CLSN, ELOX, EGLT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18 2021 | ATOS | ATOSSA THERAPEUTIC ... | WEAVER GREGORY L | Director | Option Exercise | A | 2.90 | 50,000 | 145,000 | 50,000 | |
| May 19 2020 | ATOS | ATOSSA THERAPEUTIC ... | WEAVER GREGORY L | Director | Option Exercise | A | 1.70 | 70,000 | 119,000 | 70,000 | |
| Mar 16 2020 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | Option Exercise | M | 0.00 | 3,750 | 0 | 0 | ||
| Mar 16 2020 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | Payment of Exercise | F | 2.85 | 1,086 | 3,095 | 10,431 | 11.5 K to 10.4 K (-9.43 %) | |
| Mar 16 2020 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | Buy | M | 0.00 | 3,750 | 0 | 11,517 | 7.8 K to 11.5 K (+48.28 %) | |
| Jan 31 2020 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | CHIEF FINANCIAL OFF ... | Option Exercise | M | 0.00 | 5,000 | 0 | 15,000 | |
| Jan 31 2020 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | CHIEF FINANCIAL OFF ... | Payment of Exercise | F | 3.91 | 1,733 | 6,776 | 7,767 | 9.5 K to 7.8 K (-18.24 %) |